Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

BRD–NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells

Abstract

An unusual group of carcinomas, here termed nuclear protein in testis (NUT) midline carcinomas (NMC), are characterized by translocations that involve NUT, a novel gene on chromosome 15. In about 2/3rds of cases, NUT is fused to BRD4 on chromosome 19. Using a candidate gene approach, we identified two NMCs harboring novel rearrangements that result in the fusion of NUT to BRD3 on chromosome 9. The BRD3–NUT fusion gene encodes a protein composed of two tandem chromatin-binding bromodomains, an extra-terminal domain, a bipartite nuclear localization sequence, and almost the entirety of NUT that is highly homologous to BRD4–NUT. The function of NUT is unknown, but here we show that NUT contains nuclear localization and export sequences that promote nuclear-cytoplasmic shuttling via a leptomycin-sensitive pathway. In contrast, BRD3–NUT and BRD4–NUT are strictly nuclear, implying that the BRD moiety retains NUT in the nucleus via interactions with chromatin. Consistent with this idea, FRAP studies show that BRD4, BRD4–NUT and BRD3–NUT have significantly slower rates of lateral nuclear diffusion than that of NUT. To investigate the functional role of BRD–NUT fusion proteins in NMCs, we investigated the effects of siRNA-induced BRD3–NUT and BRD4–NUT withdrawal. Silencing of these proteins in NMC cell lines resulted in squamous differentiation and cell cycle arrest. Together, these data suggest that BRD–NUT fusion proteins contribute to carcinogenesis by associating with chromatin and interfering with epithelial differentiation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K . (2003). The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci USA 100: 8758–8763.

    Article  CAS  Google Scholar 

  • Farina A, Hattori M, Qin J, Nakatani Y, Minato N, Ozato K . (2004). Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization. Mol Cell Biol 24: 9059–9069.

    Article  CAS  Google Scholar 

  • Fornerod M, Ohno M, Yoshida M, Mattaj IW . (1997). CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90: 1051–1060.

    Article  CAS  Google Scholar 

  • French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA et al. (2004). Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22: 4135–4139.

    Article  CAS  Google Scholar 

  • French CA, Miyoshi I, Aster JC, Kubonishi I, Kroll TG, Dal Cin P et al. (2001). BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol 159: 1987–1992.

    Article  CAS  Google Scholar 

  • French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA . (2003). BRD4–NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63: 304–307.

    CAS  PubMed  Google Scholar 

  • Haruki N, Kawaguchi KS, Eichenberger S, Massion PP, Gonzalez A, Gazdar AF et al. (2005). Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro. J Med Genet 42: 558–564.

    Article  CAS  Google Scholar 

  • Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K . (2005). The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 19: 523–534.

    Article  CAS  Google Scholar 

  • Kees UR, Mulcahy MT, Willoughby ML . (1991). Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatr Hematol Oncol 13: 459–464.

    Article  CAS  Google Scholar 

  • Maruyama T, Farina A, Dey A, Cheong J, Bermudez VP, Tamura T et al. (2002). A mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase. Mol Cell Biol 22: 6509–6520.

    Article  CAS  Google Scholar 

  • Mertens F, Wiebe T, Adlercreutz C, Mandahl N, French CA . (2006). Successful treatment of a child with t(15;19)-positive tumor. Pediatr Blood Cancer; e-pub ahead of print; 2 January 2007.

    Article  Google Scholar 

  • Ossareh-Nazari B, Bachelerie F, Dargemont C . (1997). Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278: 141–144.

    Article  CAS  Google Scholar 

  • Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, Schulz TF . (2006). The Kaposi’s Sarcoma-associated Herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3- induced G1 cell cycle arrest. J Virol 80: 10772–10786.

    Article  CAS  Google Scholar 

  • Toretsky JA, Jenson J, Sun CC, Eskenazi AE, Campbell A, Hunger SP . (2003). Translocation (11;15;19): a highly specific chromosome rearrangement associated with poorly differentiated thymic carcinoma in young patients. Am J Clin Oncol 26: 300–306.

    PubMed  Google Scholar 

  • Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K et al. (2005). Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 19: 535–545.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Drs Andrew Weng and Stephen Blacklow for helpful advice and discussion. CAF is supported by a grants from the National Cancer Institute.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C A French.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

French, C., Ramirez, C., Kolmakova, J. et al. BRD–NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27, 2237–2242 (2008). https://doi.org/10.1038/sj.onc.1210852

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210852

Keywords

This article is cited by

Search

Quick links